IMPACT OF GOLIMUMAB ON PHYSICAL FUNCTION AND EMPLOYABILITY OF PATIENTS WITH RHEUMATOID ARTHRITIS: 5-YEAR DATA FROM 3 PHASE III CLINICAL TRIALS

被引：0
|
作者：
Han, C. [1 ]
Keystone, E. [2 ]
Fleischmann, R. [3 ]
Smolen, J. [4 ,5 ]
Matteson, E. L. [6 ]
Emery, P. [7 ,8 ]
Genovese, M. [9 ]
Gathany, T. [1 ]
Hsia, E. C. [10 ,11 ]
机构：
[1] Johnson & Johnson Pharmaceut Serv LLC, Malvern, PA USA
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[4] Med Univ Vienna, Vienna, Austria
[5] Hietzing Hosp, Vienna, Austria
[6] Mayo Clin, Rochester, NY USA
[7] Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England
[8] Univ Leeds, Leeds, W Yorkshire, England
[9] Stanford Univ, Palo Alto, CA 94304 USA
[10] Janssen Res & Dev LLC, Spring House, PA USA
[11] Univ Penn, Philadelphia, PA 19104 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.2535
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0156
引用
收藏
页码：234 / 234
页数：1
相关论文
共 50 条
  • [1] Impact of Golimumab on Physical Function and Employability of Patients with Rheumatoid Arthritis: 5-Year Data from 3 Phase III Clinical Trials
    Han, Chenglong
    Keystone, Edward C.
    Fleischmann, Roy
    Smolen, Josef S.
    Matteson, Eric L.
    Emery, Paul
    Genovese, Mark C.
    Gathany, Timothy A.
    Hsia, Elizabeth C.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1090 - S1090
  • [2] LONG-TERM GOLIMUMAB PERSISTENCE: 5-YEAR TREATMENT RETENTION DATA POOLED FROM FIVE PHASE III CLINICAL TRIALS IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS
    Weinstein, C.
    Govoni, M.
    Lin, J.
    Meehan, A.
    Qureshi, Z.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 777 - 778
  • [3] Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    Kay, Jonathan
    Fleischmann, Roy
    Keystone, Edward
    Hsia, Elizabeth C.
    Hsu, Benjamin
    Zhou, Yiying
    Goldstein, Neil
    Braun, Juergen
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (12) : 2120 - 2130
  • [4] Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
    Cindy L. J. Weinstein
    Alan G. Meehan
    Jianxin Lin
    Steven D. Briscoe
    Marinella Govoni
    Clinical Rheumatology, 2023, 42 : 3397 - 3405
  • [5] Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
    Weinstein, Cindy L. J.
    Meehan, Alan G.
    Lin, Jianxin
    Briscoe, Steven D.
    Govoni, Marinella
    CLINICAL RHEUMATOLOGY, 2023, 42 (12) : 3397 - 3405
  • [6] Sustained Improvement In Health-Related Quality Of Life, Work Productivity, Employability, and Reduced Healthcare Resource Utilization Of Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Treated With Golimumab: 5-Year Results From 3 Phase III Studies
    Han, Chenglong
    Kavanaugh, Arthur
    Genovese, Mark C.
    Hsu, Benjamin
    Deodhar, Atul A.
    Hsia, Elizabeth C.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S137 - S137
  • [7] SUSTAINED IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE, WORK PRODUCTIVITY, EMPLOYABILITY AND REDUCED HEALTHCARE RESOURCE UTILIZATION OF PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS TREATED WITH GOLIMUMAB: 5-YEAR RESULTS FROM THREE PHASE III STUDIES
    Han, Chenglong
    Kavanaugh, Arthur
    Genovese, Mark C.
    Deodhar, Atul
    Hsu, Ben
    Hsia, Elizabeth
    RHEUMATOLOGY, 2014, 53 : 74 - 74
  • [8] 5-YEAR DATA FROM TENDER, A PHASE III CLINICAL TRIAL: SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
    Baildam, Eileen
    De Benedetti, Fabrizio
    Ruperto, Nicola
    Brunner, Hermine
    Keane, Caroline
    Wells, Chris
    Wang, Jianmei
    Calvo, Inmaculada
    Cuttica, Ruben
    Ravelli, Angello
    Schneider, Rayfel
    Eleftheriou, Despina
    Wouters, Carine
    Xavier, Ricardo
    Zemel, Lawrence
    Burgos-Vargas, Ruben
    Dolezalova, Pavla
    Garay, Stella M.
    Joos, Rik
    Grom, Alexei
    Wulffraat, Nico
    Zuber, Zbyszek
    Zulian, Francesco
    Martini, Alberto
    Lovell, Daniel
    RHEUMATOLOGY, 2016, 55 : 56 - 56
  • [9] FINAL 5-YEAR SAFETY AND EFFICACY RESULTS OF A PHASE 3, RANDOMIZED PLACEBO-CONTROLLED TRIAL OF GOLIMUMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE
    Keystone, Edward
    Genovese, Mark C.
    Hall, Stephen
    Miranda, Pedro C.
    Bae, Sang-Cheol
    Han, Chenglong
    Gathany, Tim
    Zhou, Yiying
    Xu, Stephen
    Hsia, Elizabeth C.
    RHEUMATOLOGY, 2014, 53 : 99 - 99
  • [10] CLINICAL MEANINGFULNESS OF RADIOGRAPHIC JOINT DAMAGE ON PHYSICAL FUNCTION, EMPLOYABILITY AND WORK PRODUCTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE INTRAVENOUS GOLIMUMAB STUDY, GO-FURTHER
    Han, C.
    Bingham, C. O.
    Westhovens, R.
    Weinblatt, M. E.
    Kim, L.
    Baker, D.
    Peterson, S.
    Hsia, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1031 - 1031
12345